Kirby brings extensive experience across a broad spectrum of senior and executive leadership roles within the healthcare industry. His background spans managed care, specialty pharmacy, oncology utilization management strategies, business development, healthcare consulting, healthcare technology, provider network development, group purchasing, specialty distribution, and pharmaceutical manufacturing.

Prior to joining OutcomeRx, Kirby held key leadership positions with high-profile organizations, including D2 Solutions, Onco360, CVS Health, CuraScript/Express Scripts, US Oncology, Oncology Therapeutics Network, Sicor, Fujisawa, and Eli Lilly & Company.

As Chief Clinical Officer at OutcomeRx, Kirby leads the development and implementation of patient-centered clinical solutions for cell and gene therapies. His work focuses on aligning stakeholders with cost-effective approaches that complement OutcomeRx’s innovative reinsurance and therapy warranty models. He also oversees the creation of personalized patient support services that address both the clinical and financial complexities associated with advanced therapies, while also considering the needs of caregivers.

Kirby is a licensed pharmacist with a B.S. in Pharmacy from the Arnold & Marie Schwartz College of Pharmacy. He is an active member of the American Society of Gene & Cell Therapy (ASGCT), the National Association of Specialty Pharmacy (NASP), and the Academy of Managed Care Pharmacy (AMCP). His insights and expertise have been featured in numerous professional publications, including the Journal of NCCN, Specialty Pharmacy Times, Drug Topics, and the Journal of Managed Care.